HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Submit a response Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Memarsadeghi, M. Articles by Helbich, T. H. Search for Related Content PubMed PubMed Citation Articles by Memarsadeghi, M. Articles by Helbich, T. H.

Axillary Lymph Node Metastases in Patients with Breast Carcinomas: Assessment with Nonenhanced versus USPIO-enhanced MR Imaging¹

¹ From the Departments of Radiology (M.M., C.C.R., A.K., W.M., T.H.H.), Gynecology (A.G.), and Pathology (M.R.), Medical University Vienna, General Hospital of Vienna, Waehringer Guertel 18-20, A-1090 Vienna, Austria. From the 2003 RSNA Annual Meeting. Received April 26, 2005; revision requested June 22; revision received August 9; accepted September 7; final version accepted February 1, 2006. Address correspondence to M.M. (e-mail: mazda.memarsadeghi{at}meduniwien.ac.at).

Purpose: To prospectively assess the accuracy of nonenhanced versus ultrasmall superparamagnetic iron oxide (USPIO)–enhanced magnetic resonance (MR) imaging for depiction of axillary lymph node metastases in patients with breast carcinoma, with histopathologic findings as reference standard.

Materials and Methods: The study was approved by the university ethics committee; written informed consent was obtained. Twenty-two women (mean age, 60 years; range, 40–79 years) with breast carcinomas underwent nonenhanced and USPIO-enhanced (2.6 mg of iron per kilogram of body weight intravenously administered) transverse T1-weighted and transverse and sagittal T2-weighted and T2*-weighted MR imaging in adducted and elevated arm positions. Two experienced radiologists, blinded to the histopathologic findings, analyzed images of axillary lymph nodes with regard to size, morphologic features, and USPIO uptake. A third independent radiologist served as a tiebreaker if consensus between two readers could not be reached. Visual and quantitative analyses of MR images were performed. Sensitivity, specificity, and accuracy values were calculated. To assess the effect of USPIO after administration, signal-to-noise ratio (SNR) changes were statistically analyzed with repeated-measurements analysis of variance (mixed model) for MR sequences.

Results: At nonenhanced MR imaging, of 133 lymph nodes, six were rated as true-positive, 99 as true-negative, 23 as false-positive, and five as false-negative. At USPIO-enhanced MR imaging, 11 lymph nodes were rated as true-positive, 120 as true-negative, two as false-positive, and none as false-negative. In two metastatic lymph nodes in two patients with more than one metastatic lymph node, a consensus was not reached. USPIO-enhanced MR imaging revealed a node-by-node sensitivity, specificity, and accuracy of 100%, 98%, and 98%, respectively. At USPIO-enhanced MR imaging, no metastatic lymph nodes were missed on a patient-by-patient basis. Significant interactions indicating differences in the decrease of SNR values for metastatic and nonmetastatic lymph nodes were found for all sequences (P < .001 to P = .022).

Conclusion: USPIO-enhanced MR imaging appears valuable for assessment of axillary lymph node metastases in patients with breast carcinomas and is superior to nonenhanced MR imaging.

© RSNA, 2006

This article has been cited by other articles:

				M. Neri, C. Maderna, C. Cavazzin, V. Deidda-Vigoriti, L. S. Politi, G. Scotti, P. Marzola, A. Sbarbati, A. L. Vescovi, and A. Gritti Efficient In Vitro Labeling of Human Neural Precursor Cells with Superparamagnetic Iron Oxide Particles: Relevance for In Vivo Cell Tracking Stem Cells, February 1, 2008; 26(2): 505 - 516. [Abstract] [Full Text] [PDF]

				S. D. Nathanson, M. Burke, R. Slater, and A. Kapke Preoperative Identification of the Sentinel Lymph Node in Breast Cancer Ann. Surg. Oncol., November 1, 2007; 14(11): 3102 - 3110. [Abstract] [Full Text] [PDF]

				D. J. Hsiang, M. Yamamoto, R. S. Mehta, M.-Y. Su, C. H. Baick, K. T. Lane, and J. A. Butler Predicting Nodal Status Using Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Patients With Locally Advanced Breast Cancer Undergoing Neoadjuvant Chemotherapy With and Without Sequential Trastuzumab Arch Surg, September 1, 2007; 142(9): 855 - 861. [Abstract] [Full Text] [PDF]